Mark Eisner, Chief Medical Officer: Kyntra Bio KYNB Sell · Filed 23/03/10

Trade details

Type: Insider sale
Amount: $155,801.08
Shares · price: 7,363 sh · $21.16 a share
Held after: 165,133 sh
Stock: Kyntra Bio KYNB
Person: Mark EisnerChief Medical Officer
Trade date: 23/03/08
Filed: 23/03/10
Days to filing: 2 days

Sold 4.3% of holdings

Share of holding sold: 4.3%

Kyntra Bio trades, last 26 weeks

What else happened in Kyntra Bio around then

Filed or reported within 30 days of the trade day · 23/02/06~23/04/07

Mark Eisner's recent trades

Mark EisnerFormer Officer
Planned saleVir Biotechnology
Planned sale
Vir Biotechnology
VIR
$916.3K
88,958 sh
$916.3K
Filed 04/30
Traded 04/30
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/26
Traded 02/25
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$15.4K
1,616 sh
$15.4K
Filed 02/26
Traded 02/24
Mark EisnerOfficer
Planned sale10b5-1 planVir Biotechnology
Planned sale10b5-1 plan
Vir Biotechnology
VIR
$18.5K
1,889 sh
$18.5K
Filed 02/25
Traded 02/25
Mark EisnerEVP and Chief Medical Officer
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$15.6K
2,089 sh
$15.6K
Filed 02/24
Traded 02/23